Figure 1. Outcomes by mutation status... | American Society of Hematology

Figure 1.

Figure 1. Outcomes by mutation status (KIT or FLT3 or RAS). (a) Overall survival; (b) Relapse free survival.

Outcomes by mutation status (KIT or FLT3 or RAS). (a) Overall survival; (b) Relapse free survival.

This Feature Is Available To Subscribers Only

Sign In or Create an Account